Abstract
Background
Treatment response to neoadjuvant therapy is histologically associated with more or less intensive inflammation and fibrosis. In consequence, accuracy of endosonographic TN-tumor staging after neoadjuvant treatment is hampered. We analyzed whether the kind of treatment chosen [chemoradiotherapy (CRT) or chemotherapy (CT)] differently influences the accuracy of endoscopic ultrasound after neoadjuvant therapy in esophageal cancer.
Methods
We performed serial endoscopic ultrasound examinations in 18 patients after neoadjuvant CRT and 30 patients after neoadjuvant CT. TN-stage was classified according to the standard parameter. Histological examination of the surgical resection specimen served as gold standard.
Results
The most frequent error was overstaging, especially in patients with complete tumor response or minimal residual disease. Accuracy of T-staging was significantly worse after CRT (0.16) than after CT (0.43), obviously due to difficulty in distinguishing residual tumor from treatment-associated fibrosis and inflammation. Accuracy of N-staging was also hampered, but to a less extent (sensitivity/specificity 0.85/0.36 after CRT, and 0.5/0.42 after CT).
Conclusions
Accuracy of endosonographic TN-tumor staging is significantly more hampered by neoadjuvant CRT than after CT. However, endoscopic ultrasound is insufficient for TN-staging irrespective of the kind of neoadjuvant therapy performed.
Similar content being viewed by others
References
Puli SR, Reddy JB, Antillon D, Ibdah JA, Antillon MR (2008) Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol 14:1479–1490
Wang KK, Wongkeeson ME, Buttar NS (2005) American gastroenterological association technical review on the role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology 128:1471–1505
Van Vliet EPM, Heijenbrok-Kal MH, Hunink MGM, Kuipers EJ, Siersema PD (2008) Staging investigations for oesophageal cancer: a meta-analysis. B J Cancer 98:547–557
Stahl M, Mariette C, Haustermans K, Cervantes A, Arnold D, on behalf of the ESMO Guidelines Working Group (2013) Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24((Supplement 6)):vi51–vi56
Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D, Mayer R (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086–1092
Agarwal B, Swicher S, Ajani J, Kelly K, Fannin C, Komaki RR, Putnam JB, Abu-Hamda E, Molke KL, Walsch GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA (2004) Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol 99:1258–1266
Willis J, Cooper GS, Isenberg G, Sivak MV, Levitan N, Clayman J, Chak A (2002) Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy in response in esophageal carcinoma. Gastrointest Endosc 55:655–661
Griffin JM, Reed CE, Denlinger CE (2012) Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer. Ann Thorac Surg 93:1855–1860
Kalha I, Kaw M, Fukami N, Patel M, Singh S, Gagneja H, Cohen D, Morris J (2004) The accuracy of endoscopic ultrasound in restaging esophageal carcinoma after chemoradiation therapy. Cancer 101:940–947
Laterza E, Manzoni G, Guglielmi A, Rodalle L, Tedesco P, Cordianl C (1999) Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann Thorac Surg 67:1466–1469
Zuccaro G, Rice TW, Goldblum J, Medendorp SV, Becker M, Pimentel R, Gitlin L, Adelstein DJ (1999) Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 94:906–912
Lorenzen S, Thuss-Patience P, Al-Batran SE, Lordick F, Haller B, Schuster T, Pauligk C, Luley K, Biches D, Schumacher G, Homann N (2013) Impact of complete pathologic response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy. Ann Oncol 24:2068–2074
Mesenas S, Vu C, McStay M, Doig L, Mason R, Boyle N, Meenan J (2008) A large series, resection controlled study to assess the value of radial EUS in restaging gastroesophageal cancer following neoadjuvant chemotherapy. Dis Esophag 21:37–42
Misra S, Choi M, Livingstone AS, Franceschi D (2012) The role of endoscopic ultrasound in assessing tumor response and staging after neoadjuvant chemotherapy for esophageal cancer. Surg Endosc 26:518–522
Catalano MF, Sivak MV Jr, Rice T, Gragg LA, van Dam J (1994) Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc 40:442–446
Heinzow HS, Seifert H, Tsepetonidis S, Wolters H, Kucharzik T, Doschke W, Domagk D, Meister T (2013) Endoscopic ultrasound in staging esophageal cancer after neoadjuvant chemotherapy—results of a multicenter cohort analysis. J Gastrointest Surg 17:1050–1057
Bohle W, Clemens P, Tran D, Zoller WG (2011) Stellenwert der Endosonografie bei der Therapieplanung des resektablen Ösophaguskarzinoms. Z Gastroenterol 49:1102
Chak A, Canto MI, Cooper GS, Isenberg G, Willis J, Levithan N, Clayman J, Forastiere A, Heath E, Sivak MV (2000) Endosonographic assessment of multimodality therapy predicts survival of esophageal cancer patients. Cancer 88:1788–1795
Ribeiro A, Franceschi D, Parra J, Livingstone A, Lima M, Hamilton-Nelson K, Ardala B (2006) Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer. Am J Gastroenterol 101:1216–1221
Machlenkin S, Lezler E, Ideleich E, Ziv-Sokolovsky N, Klein Y, Kahstan H (2009) Endoscopic ultrasound: doubtful accuracy for restaging esophageal cancer after preoperative chemotherapy. IMAJ 11:166–169
Bowrey DJ, Clark GWB, Roberts A, Hawthorne AB, Maugham TS, Williams GT, Carey PD (1999) Serial endoscopic ultrasound in the assessment of response to chemoradiotherapy for carcinoma of the esophagus. J Gastrointest Surg 3:462–467
Eloubeidi MA, Cerfolio RJ, Bryani AS, Varadaraiulu S (2011) Efficacy of endoscopic ultrasound in patients with esophageal cancer predicted to have N0 disease. Eur J Cardiothorac Surg 40:636–641
Chandawarkar RY, Kakegawa T, Fujita H, Yamana H, Toh Y, Fujitoh H (1996) Endosonography for preoperative staging of specific nodal groups associated with esophageal cancer. World J Surg 20:700–702
Menzel J, Hoepffner N, Nottberg H, Schulz C, Senninger N, Domschke W (1999) Preoperative staging of esophageal carcinoma: miniprobe sonography versus conventional endoscopic ultrasound in a prospective histopathologically verified study. Endoscopy 31:291–297
Giovannini M, Seitz JF, Thomas P, Hannoun-Levy JM, Perrier Resbeut M, Delpero JR, Fuentes P (1997) Endoscopic ultrasonography for assessment of the response to combined radiation therapy and chemotherapy in patients with esophageal cancer. Endoscopy 29:4–9
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
W. Bohle, M. Kasper and W. G. Zoller have no conflicts of interest or financial ties to disclose.
Rights and permissions
About this article
Cite this article
Bohle, W., Kasper, M. & Zoller, W.G. Different accuracy of endosonographic tumor staging after neoadjuvant chemotherapy and chemoradiotherapy in esophageal cancer. Surg Endosc 30, 2922–2928 (2016). https://doi.org/10.1007/s00464-015-4578-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-015-4578-y